• Home
  • Team
  • Services
  • Portfolio
    • Cleantech
      • Consulting Energy Control
      • Lumartix
      • PVSyst
    • Healthcare
      • Anteis
      • Augurix
      • BioXpress Therapeutics
      • Leman Medical Technologies
      • Medicontur
      • Powersens
      • Viroblock
    • ICT
      • Abilis
      • inZair
      • Tegona
    • IT
      • salsaDev
    • Life Sciences
      • Selexis
    • Nanotechnology
      • Dextens
      • Manep
      • Phasis
  • Partners
    • VentureLab
    • Venture Kick
    • CTI
    • CTI Startup
    • CTI Invest
    • AlpICT
    • CleantechAlps
    • Eclosion
    • Economic Development Service
    • OPI
    • HUG
    • UNITEC
    • MedC Partners
    • BlueOcean Ventures
    • Business Angels Switzerland
    • Startup Weekend
  • FAQ
  • News
  • Investors
  • Accelerators
  • Workshops
  • Jobs Board
  • Apply
  • Contact

FONGIT

The Start up Factory

BlueOcean Ventures

May 6, 2011 by admin

BlueOcean is an investment company dedicated to investing in Swiss Hi-Tech early stage projects. Our primary focus is on Swiss high technology: ICT, medtech, environment and engineering sectors with superior international potential. We invest usually up to 1.5m CHF.

Our investors are family offices and high net worth individuals attracted by the quality of our deal-flow, our track record and the opportunity to co-invest with reputed venture capital firms. Our investors are private individuals attracted by the potential and reputation of Swiss-made products and achievements, family offices eager to benefit from a high-return asset category in a safer-than-usual environment, sophisticated investors with a direct personal interest in hi-tech hi-growth projects and a desire to exploit early stage opportunities.

Filed Under: Augurix, BlueOcean Ventures, Venture Capital, Viroblock

Viroblock

May 3, 2011 by admin

Viroblock aims to launch a break through anti-viral face mask by mid 2012. Current face-masks (surgical, FFP2, N95) provide limited protection to wearers against respiratory viruses (H1N1,H5N1, SARS, RSV, etc) as they fail to filter out or kill these viruses. The new Viroblock mask uses a patented coating to kill all such viruses on pass through air thereby protecting the wearer and reducing infection.

Targeted first at professionals who have a risk of viral infections (e.g., dentists, A&E staff, first responders). Viroblock technology has been shown to kill all enveloped viruses tested, including H1N1, H5N1, SARS, HIV and HSV. No resistance has been seen nor is expected as Viroblock technology targets a non-coded part of these viruses. Viroblock’s technology can be used in other products (e.g. nasal spray, vaginal gel).

Filed Under: Featured, Fongit, Healthcare, Viroblock

VentureKick VentureLab Aesthetic dermatology (1)
AFM (1)
Antibodies (1)
Artery banding (1)
Augurix (1)
Bio-therapeutics (1)
Biopolymers (1)
Biosimilar (2)
BlueOcean Ventures (1)
Cataract (1)
Cell-based assay (1)
Cell-line development (1)
Cleantech (2)
Consulting (2)
Content Analytics (1)
CTI (3)
CTI Start up (2)
Dextens (1)
Diagnostic (1)
Epigenetics (1)
Featured (9)
FloWatch (1)
Fongit (13)
Fongit Seed Invest (5)
Foot (1)
Funding (4)
Gaming (1)
gene expression (1)
Geolocalisation (1)
Hard skills (1)
Healthcare (5)
Injectable (1)
InjectNow (1)
Innovation (3)
Intraocular lens implant (1)
Investment (3)
Legal (1)
MedTech (3)
Messaging (1)
Metallurgy (1)
Micro-credit (1)
Micro-health (1)
Micro-insurance (1)
Microscopy (1)
Microscopy substrate (1)
NFC (1)
Ophthalmology (1)
Orthopaedic (1)
Orthopaedics (1)
PAB (1)
Plantar pressure (1)
Private Equity (1)
Protein expression (1)
Protein production (1)
R&D (1)
Recombinant proteins (1)
Recruiters (1)
SalsaDev (1)
Security (1)
Semantic (1)
Semantic Meaning (1)
Sensors (2)
Shoe-insole (1)
Smartcard (1)
Soft skills (1)
Space-time (1)
Sport (1)
STM (1)
Superconductor (1)
Talent matching (1)
Thin film (2)
Training (1)
Value network (1)
Venture Capital (3)
Viroblock (2)
Wireless (1)
Workshops (2)
ZMS (1)

WP Cumulus Flash tag cloud by Roy Tanck requires Flash Player 9 or better.

Return to top of page

Copyright FONGIT © 2012 · Terms of Use · Log in